During the past decade, San Raffaele Pisana conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "San Raffaele Pisana" are "Coronary Artery Disease" (3 trials), "Ischemic Heart Disease" (2 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Diseases" (1 trials) and "Interventional Cardiology" (1 trials). Many other conditions were trialed in "San Raffaele Pisana" in a lesser frequency.

Most popular intervention types in "San Raffaele Pisana" are "Drug" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ranolazine" (2 trials), "Amlodipine" (1 trials), "Aspirin, Atorvastatin, Perindopril" (1 trials), "Chronic administration of dabigatran, rivaroxaban, apixaban, or edoxaban" (1 trials) and "Ezetimibe" (1 trials). Other intervention names were less common.

The vast majority of trials in "San Raffaele Pisana" are 6 trials for "All" genders.

Currently, there are NaN active trials in "San Raffaele Pisana". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in San Raffaele Pisana, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in San Raffaele Pisana, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".